PHARVARIS NV Insider Lu Peng Executes 15,000‑Share Buy at $2.59, While Selling at $40.30 in Structured 10 b5‑1 Trades—Market Sees Positive Sentiment Amid Dilution Concerns

Insider Activity Highlights for PHARVARIS NV

Lu Peng’s Dual Role and Recent Trading Pattern On September 11, 2026, President Lu Peng executed a 15,000‑share purchase under the company’s 10 b5‑1 trading plan, paying $2.59 per share – a price far below the market level of $33.05. This buy is part of a series of planned trades that began in early June, with Lu Peng alternating between large buy and sell blocks of common stock and exercising stock options. The most recent sell on the same day was also under the 10 b5‑1 plan, with shares priced between $40.00 and $40.30. Lu Peng’s trading cadence reflects a disciplined, schedule‑driven approach rather than opportunistic market timing, suggesting a focus on maintaining liquidity and meeting vesting obligations without exerting market pressure.

Implications for Investors and Company Outlook The timing of these trades coincides with a modest weekly price increase (1.23%) and a strong year‑to‑date gain of 63.61%. The 10 b5‑1 plan’s fixed prices mean investor sentiment is largely insulated from short‑term price swings, reducing the risk of a sudden dilution shock. However, the high volume of scheduled sales—especially in late August and early September—could signal that insiders are preparing for future equity offerings or cash‑in scenarios. If the company’s clinical milestones are met, the dilution risk may be offset by a share price rally, but until then, frequent secondary sales could weigh on shareholder value.

Lu Peng’s Transaction Profile Lu Peng’s historical activity shows a pattern of buying and selling roughly equal volumes, with a slight bias toward selling. He has exercised multiple stock options (e.g., 14,700 shares on 26 June and 15,000 on 25 June) and sold option‑held shares shortly after vesting. His holding of 65,179 shares after the September 11 buy positions him as a significant but not controlling shareholder. Compared to other insiders—such as CEO Modig, who has sold over 2,000 shares in a single trade—Lu Peng’s transactions are more granular, reflecting a methodical approach to portfolio management.

Market Context and Sentiment The social‑media buzz surrounding the September 11 trades is high (101.49 %), with a positive sentiment score of +50. This indicates that the community is watching PHARVARIS closely, likely due to its high‑risk, high‑reward pipeline. The relatively low price change (0.01%) on the day of the trade suggests that the market is absorbing the transaction without significant volatility.

Key Takeaway for Stakeholders Insider activity at PHARVARIS is driven by structured trading plans rather than speculative moves. While the frequency of sales could raise concerns about future dilution, the disciplined approach and positive market sentiment imply that insiders remain invested in the company’s long‑term prospects. Investors should monitor upcoming clinical results and any new equity issuances to gauge how these trades will play out in the context of PHARVARIS’s growth trajectory.